gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · LFCRHealthcarePharmaceuticals

Lifecore Biomedical, Inc. Common Stock (LFCR)

$6.44+0.31%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$6.44▼ 5.01% in range
Nov 4, 2025Low $3.66 · High $8.82Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Lifecore Biomedical closed at $6.44 on Nov 4, up 0.31%, 27.0% below its 52-week closing high. Volume of 270.8K shares was 0.51× its 20-day average (below normal).

Split-adjusted performance: -0.2% over one month, +29.8% over six months, -9.4% over one year.

In the quarter ended Jun 30, 2026, revenue was $34.17M, with a net margin of -20.9%.

Short interest was 1.8M shares at the Oct 15 settlement, down 27.2% from the prior report (7.4% of float, 2.8 days to cover).

Market cap$244.1M37.9M shares
Revenue · quarter$34.2M—
Diluted EPS$-0.19—
P/E · TTM—
Net margin-20.9%Gross 35.3%
Dividend yieldNone
52-week range3.66 – 8.82−27.0% from high
Volume270.8K0.51× 20-day avg
Volatility · 60d96.7%Annualised
Short % of float7.4%2.8 days to cover
Net cash-$136.9MCash $17.2M
Next earnings—Not scheduled
Split-adjusted performance
1W −1.1%1M −0.2%3M +33.1%6M +29.8%YTD −21.3%1Y −9.4%3Y −9.2%5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum86
Revenue growth—
Net margin56
Value (low P/E)—
Size51

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →
Shares short1.8M−27.2% vs prior
Days to cover2.8Settled Oct 15
% of float7.4%
Short vol. 10d24.3%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
LFCRLifecore Biomedical$6.44+0.31%+29.8%—−20.9%—$244.1M
IMRXImmuneering$3.76+2.17%−27.6%———$243.5MCompare
KRROKorro Bio$16.62+4.79%+24.6%−100.0%——$244.7MCompare
LABStandard BioTools$0.6160+0.85%−36.4%−0.9%69.6%1.8$243.1MCompare
ABEOAbeona Therapeutics$4.22−0.71%−29.8%+2745.0%−177.4%—$241.3MCompare
GLSIGreenwich LifeSciences$16.35+2.70%−29.1%———$240.0MCompare
CAMPCAMP4 Therapeutics$3.74−2.35%−7.9%+18.8%−1884.8%—$234.7MCompare
VNDAVanda Pharmaceuticals$3.88+3.47%−47.8%+24.1%−32.3%—$234.6MCompare
SIGASIGA Technologies$3.15+1.29%−33.0%−49.5%30.4%—$226.3MCompare

News about Lifecore Biomedical

All news →
Halper Sadeh LLC is Investigating Whether MG, LFCR, MGLD are Obtaining Fair Deals for their ShareholdersGlobeNewswire Inc. · Oct 4, 2026▼ NegativePomerantz LLP and The Rosen Law Firm, P.A. Announce Proposed Class Action Settlement on Behalf of Purchasers of Lifecore Biomedical, Inc. Securities - LFCRGlobeNewswire Inc. · Apr 6, 2026▼ NegativeLifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics CompanyGlobeNewswire Inc. · Mar 23, 2026▲ PositiveLifecore Biomedical Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their LossesGlobeNewswire Inc. · Mar 16, 2026▼ Negative

Quick answers

What does Lifecore Biomedical do?
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.
What is LFCR's market cap?
$244.11M, based on the Nov 4 close of $6.44.
Does Lifecore Biomedical pay a dividend?
No regular cash dividend has been paid in the last year.
How much of LFCR is sold short?
1.8M shares, 7.4% of float, as of Oct 15, 2026.
What sector is LFCR in?
Healthcare, in the Pharmaceuticals industry.

About Lifecore Biomedical

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

HQ: Chaska, MN382 employeesListed Feb 15, 1996lifecore.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology